This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
March 21, 2012 /PRNewswire/ -- Cenveo, Inc. (NYSE: CVO, "Cenveo" or the "Company") announced today that its wholly-owned subsidiary, Cenveo Corporation, has amended (the "Amendment") its offer to purchase for cash (the "Offer") its outstanding 7 7/8% senior subordinated notes due 2013 (the "7 7/8% Notes"), which Offer was previously announced on
February 29, 2012 and amended on
March 12, 2012. The Amendment (i) amends the offer to purchase the 7 7/8% Notes to reduce the amount of 7 7/8% Notes subject to the Offer to an amount of up to
$45 million aggregate principal amount of 7 7/8% Notes, subject to proration procedures as set forth in Supplement No. 2 ("Supplement No. 2") to the Offer to Purchase, dated
March 21, 2012, at a total consideration of 100.25% of outstanding principal thereof plus any accrued and unpaid interest for 7 7/8% Notes accepted by the Company, validly tendered and not withdrawn by the extended total consideration payment deadline as set forth below, (ii) extends the deadline for payment of the total consideration with respect to the offer to purchase 7 7/8% Notes, as well as the deadline for withdrawal rights for the 7 7/8% Notes, to
New York City time, on
March 23, 2012, (iii) extends the expiration date with respect to the offer to purchase 7 7/8% Notes to
New York City time, on
April 3, 2012, and (iv) rescinds the solicitation of consents to amend the indenture governing the 7 7/8% Notes. The Amendment does not in any way change the terms related to the 8 3/8% senior subordinated notes due 2014 (the "8 3/8% Notes") or the 10 1/2% senior unsecured notes due 2016 (the "10 1/2% Notes" and together with the 7 7/8% Notes and the 8 3/8% Notes, the "Securities"), including the consent payment deadline and expiration date applicable to the 8 3/8% Notes and the 10 1/2% Notes.
The terms and conditions of the Offer are set forth in the Offer to Purchase, dated
February 29, 2012, as amended by Supplement No. 1 to the Offer to Purchase, dated
March 12, 2012, and as further amended by Supplement No. 2, dated
March 21, 2012, and the related Letter of Transmittal, dated
February 29, 2012.
Except for the modifications described above, all other terms and conditions of the Offer remain unchanged. Holders who have previously tendered Securities do not need to re-tender their Securities or take any other action in response to this Amendment.